Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed Mar 19, 2015 · 10-K · 75 days after period end · 0001415889-15-000967
| Metric | Q4 2014 | Q4 2013 | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $4.24M | $2.40M | $3.52M | — |
| Net Income | -$1.23M | -$724.32K | -$1.70M | — |
| EPS Diluted | -$0.03 | -$0.01 | — | — |
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jan 3, 2015 · filed Mar 19, 2015 · 75 d after period end
